Isolation of resistomycin from a terrestrial actinomycete with trail resistance-overcoming activity

Xuefeidan Liu; Midori A. Arai; Kazufumi Toume; Masami Ishibashi

doi:10.1177/1934578x1801300119

Isolation of resistomycin from a terrestrial actinomycete with trail resistance-overcoming activity

Xuefeidan Liu, Midori A. Arai, Kazufumi Toume, Masami Ishibashi

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) potently induces apoptosis in most cancer cells, but not in normal cells, and, thus, has attracted intense interest as a promising antitumor agent. Activity-guided fractionation of the culture broth of the actinomycete CKK1172 strain led to the isolation of the antibiotic resistomycin (1) using human gastric adenocarcinoma AGS cells. Compound 1 exhibited TRAIL resistance-overcoming activity at 2 μM with 38% more inhibition than a treatment with 1 alone (without TRAIL) in TRAIL-resistant AGS cells.

Original language	English
Pages (from-to)	65-66
Number of pages	2
Journal	Natural product communications
Volume	13
Issue number	1
DOIs	https://doi.org/10.1177/1934578x1801300119
Publication status	Published - 2018 Jan
Externally published	Yes

Keywords

Actinomycete
Resistomycin
TRAIL resistance-overcoming activity

ASJC Scopus subject areas

Pharmacology
Plant Science
Drug Discovery
Complementary and alternative medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/1934578x1801300119

Cite this

@article{a32c516c88374efd84301d34f1bb1f3b,

title = "Isolation of resistomycin from a terrestrial actinomycete with trail resistance-overcoming activity",

abstract = "Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) potently induces apoptosis in most cancer cells, but not in normal cells, and, thus, has attracted intense interest as a promising antitumor agent. Activity-guided fractionation of the culture broth of the actinomycete CKK1172 strain led to the isolation of the antibiotic resistomycin (1) using human gastric adenocarcinoma AGS cells. Compound 1 exhibited TRAIL resistance-overcoming activity at 2 μM with 38% more inhibition than a treatment with 1 alone (without TRAIL) in TRAIL-resistant AGS cells.",

keywords = "Actinomycete, Resistomycin, TRAIL resistance-overcoming activity",

author = "Xuefeidan Liu and Arai, {Midori A.} and Kazufumi Toume and Masami Ishibashi",

year = "2018",

month = jan,

doi = "10.1177/1934578x1801300119",

language = "English",

volume = "13",

pages = "65--66",

journal = "Natural Product Communications",

issn = "1934-578X",

publisher = "Natural Product Communications",

number = "1",

}

TY - JOUR

T1 - Isolation of resistomycin from a terrestrial actinomycete with trail resistance-overcoming activity

AU - Liu, Xuefeidan

AU - Arai, Midori A.

AU - Toume, Kazufumi

AU - Ishibashi, Masami

PY - 2018/1

Y1 - 2018/1

N2 - Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) potently induces apoptosis in most cancer cells, but not in normal cells, and, thus, has attracted intense interest as a promising antitumor agent. Activity-guided fractionation of the culture broth of the actinomycete CKK1172 strain led to the isolation of the antibiotic resistomycin (1) using human gastric adenocarcinoma AGS cells. Compound 1 exhibited TRAIL resistance-overcoming activity at 2 μM with 38% more inhibition than a treatment with 1 alone (without TRAIL) in TRAIL-resistant AGS cells.

AB - Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) potently induces apoptosis in most cancer cells, but not in normal cells, and, thus, has attracted intense interest as a promising antitumor agent. Activity-guided fractionation of the culture broth of the actinomycete CKK1172 strain led to the isolation of the antibiotic resistomycin (1) using human gastric adenocarcinoma AGS cells. Compound 1 exhibited TRAIL resistance-overcoming activity at 2 μM with 38% more inhibition than a treatment with 1 alone (without TRAIL) in TRAIL-resistant AGS cells.

KW - Actinomycete

KW - Resistomycin

KW - TRAIL resistance-overcoming activity

UR - http://www.scopus.com/inward/record.url?scp=85048481817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048481817&partnerID=8YFLogxK

U2 - 10.1177/1934578x1801300119

DO - 10.1177/1934578x1801300119

M3 - Article

AN - SCOPUS:85048481817

VL - 13

SP - 65

EP - 66

JO - Natural Product Communications

JF - Natural Product Communications

SN - 1934-578X

IS - 1

ER -

Isolation of resistomycin from a terrestrial actinomycete with trail resistance-overcoming activity

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this